Trailing-twelve-month (TTM) revenue is $22.11 Billion with a year-over-year growth of (1.58%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $5,579,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-28 |
| Q4 FY2025Period ended 2025-12-31 | $4,837,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-05 |
| Q1 FY2026Period ended 2026-03-31 | $5,341,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $6,351,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-28 |
| TTM revenue | $22,108,000,000 |
Current P/S: $45,420,310,641 market capitalization ÷ $22,108,000,000 TTM revenue = 2.05x.
Market capitalization source: FMP quote. Quote observed 2026-09-23T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $6.35B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-23T20:20:39.513Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product | $14.3B | $17.2B | $18.3B | $19.6B | $20.0B | $19.2B |
| Service | $3.1B | $3.4B | $2.2B | $2.5B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $2.7B | $3.5B | $3.5B | $4.4B | $3.8B | $3.8B |
| Europe | $4.9B | $5.8B | $4.4B | $4.7B |
$22.11B
$22.11 Billion
(1.58%)
vs. $22.46B a year ago (TTM)
+2.30%
5 Year compound annual growth rate
1 Year
(1.58%)
3 Year
+0.44%
5 Year
+2.30%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $21.75B | ($739.00M) | (3.29%) |
| 2024 | $22.49B | +$3.54B | +18.65% |
| 2023 | $18.95B | +$1.66B | +9.62% |
| 2022 | $17.29B | ($3.33B) | (16.13%) |
| 2021 | $20.61B | +$3.16B | +18.09% |
| 2020 |
TTM Growth
(1.58%)
3-Year CAGR
+0.44%
5-Year CAGR
+2.30%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-23T20:20:39.513Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.5B |
| $2.6B |
| $6.1B |
| Other Geographical Region | $761M | $881M | $776M | $812M | $688M | $678M |
|---|
| UNITED STATES | $9.1B | $10.5B | $11.8B | $12.2B | $11.3B | $11.1B |
|---|
| $17.46B |
| ($1.15B) |
| (6.19%) |
| 2019 | $18.61B | ($306.00M) | (1.62%) |
| 2018 | $18.91B | +$1.10B | +6.17% |
